Hi Rebecca,
Don’t mean to be rude, but Exchanger is correct, your statement is very misleading. The Biomuse study was only still finishing enrollment recently ( 80% complete as per last quarterly report) and the study will be ongoing for 12 months as per the slides from the 10th March Global life Science conference. This means the study will not be completed until mid next year. I suggest you re read page 19 of that report which clearly shows Phase 2 commencement will begin later this year and run simultaneously with the trial.
The trial will definitely start before the completion of the study. FDA will use that information to help Alterity extract endpoints - as it was at their suggestion they do this Biomuse study in the first place by my recollection.
- Forums
- ASX - By Stock
- ATH
- Any news ??, up in NY 8%
Any news ??, up in NY 8%, page-12
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.62M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $4.887K | 1.626M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
48 | 57027004 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 125241201 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
48 | 57027004 | 0.003 |
52 | 82308597 | 0.002 |
25 | 120860100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 125241201 | 25 |
0.005 | 28735782 | 26 |
0.006 | 14397472 | 18 |
0.007 | 47726651 | 22 |
0.008 | 22799732 | 22 |
Last trade - 10.38am 02/09/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |